VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia.
Safety and clinical activity of 5-aza-2'-deoxycytidine (decitabine) with or without Hyper-CVAD in relapsed/refractory acute lymphocytic leukaemia. Br J Haematol. 2014 Nov; 167(3):356-65.
View in:
PubMed
subject areas
Adolescent
Adult
Aged
Antimetabolites, Antineoplastic
Antineoplastic Combined Chemotherapy Protocols
Azacitidine
Bone Marrow
Chemical and Drug Induced Liver Injury
Child
Child, Preschool
Cyclophosphamide
Cytarabine
Dexamethasone
DNA Methylation
DNA, Neoplasm
Doxorubicin
Drug Administration Schedule
Female
Gastrointestinal Diseases
Humans
Hyperglycemia
Infusions, Intravenous
Kaplan-Meier Estimate
Male
Methotrexate
Middle Aged
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Recurrence
Remission Induction
Salvage Therapy
Vincristine
Young Adult
authors with profiles
HAGOP M KANTARJIAN
MICHAEL E RYTTING
FARHAD RAVANDI-KASHANI
GUILLERMO GARCIA-MANERO
HUI YANG
ELIAS JOSEPH JABBOUR
GAUTAM BORTHAKUR
CHRISTOPHER BRENT BENTON